Latest Superannuation News

Wrkr Ltd surged revenue 52.6% to $16.2 million in FY2026 but saw net losses widen to $8.4 million as it transitioned to live Payday Super execution and integrated PaidRight. The company raised $12 million post-year-end to fuel onboarding and product growth.

Credit Clear appoints Joshua Reid as Managing Director and interim CEO of ARMA Group Holdings, signaling a leadership shift aligned with its growth ambitions across Australia and international markets.

NZX has appointed seasoned investment executive Hishaam Mirza as its new Chief Executive, aiming to boost the exchange's scale, liquidity, and international relevance.

EQT Holdings has received a nonbinding takeover proposal from TPG Global valuing the company at A$24.55 per share. The offer hinges on multiple conditions including due diligence, regulatory approvals, and board endorsement.

WAM Leaders Limited (ASX:WLE) delivered a stellar FY2026 with net profit after tax soaring 153.5% to AUD 161.8 million, driven by a 14% investment portfolio gain that outpaced the ASX 200 by 7.9%. The company declared a fully franked full year dividend of 9.6 cents per share, maintaining a strong yield amid ongoing capital raising.

Challenger Limited delivered a solid FY26 with normalised net profit after tax rising 3% to $468 million, supported by record annuity sales and strategic partnerships. The company also declared a 7% higher fully franked dividend and announced an upsized $450 million share buy-back.

Iress Limited’s half year net profit after tax surged 85% to $32 million, driven by sharp cost cuts and margin expansion, even as total revenue fell nearly 17% following recent divestments.

Fiducian Group posted solid underlying earnings growth in FY2026, boosted by a 7% rise in funds under management, advice and administration, while absorbing a one-off $7.95 million ASIC penalty that halved statutory profits.

PTR Minerals has bolstered its leadership team by appointing mineral sands veteran Colin Bwye as Non-executive Director and elevating Rob Sennitt to Managing Director, aligning with its push to develop the high-grade Rosewood Titanium Project in South Australia.

Commonwealth Bank of Australia delivered a solid FY26 with 7% growth in net profit and a strong capital position, while continuing investments in AI and customer protection.

Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.

AMP Limited reported a robust first half of 2026, with statutory profit rising 57% to $154 million and underlying profit up 33%, driven by strong Platforms growth, positive cashflows, and a doubling of China partnership contributions.